Therapeutic effect of Jinghuosu on oligospermia and asthenospermia.
- Author:
De-Feng LIU
1
;
Xue-Jun SHANG
2
;
Ji-Can DAI
3
;
Tao-Fei YAN
4
;
Zhi-Yong LIU
5
;
Long-Jie GU
6
;
Ya-Zhong JI
7
;
Lei CHEN
8
;
Hui JIANG
9
Author Information
1. Department of Reproductive Andrology, Peking University Third Hospital, Beijing 100191, China.
2. Department of Andrology, Nanjing General Hospital of Nanjing Military Region, Nanjing, Jiangsu 210002, China.
3. Department of Urology, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200240, China.
4. Department of Urology, Changhai Hospital, Shanghai 200433, China.
5. Department of Urology, Changhai Hospital, Shanghai 200433, China..
6. Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
7. Department of Urology, Tongji Hospital Affiliated to Tongji University, Shanghai 200065, China.
8. Department of Urology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
9. Department of Urology, Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- Keywords:
Jinghuosu;
asthenospermia;
male infertility;
oligospermia
- MeSH:
Asthenozoospermia;
drug therapy;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Male;
Oligospermia;
drug therapy;
Semen;
drug effects;
physiology;
Sperm Count;
Sperm Motility
- From:
National Journal of Andrology
2017;23(3):227-228
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of the compound preparation Jinghuosu on oligospermia and asthenospermia.
METHODS:This multi-centered clinical study included 120 cases of mild to moderate idiopathic oligospermia or asthenospermia, all treated with oral Jinghuosu once a bag, bid, for 3 successive months. Before and at 1, 2 and 3 months after treatment, we detected sperm concentration, total sperm motility, progressive sperm motility and normal sperm morphology of each ejaculate, and recorded whether the patients had any adverse reactions.
RESULTS:After 3 months of treatment, all the patients showed obvious improvement in semen parameters, most significantly in sperm concentration, total sperm motility, and the percentages of progressive motile sperm and morphologically normal sperm (P <0.05). No significant adverse reactions were observed during the 3 months of medication.
CONCLUSIONS:Jinghuosu has a significant efficacy and no obvious adverse effect in the treatment of mild to moderate oligospermia and asthenospermia.
